From DCAT Value Chain Insights (VCI)
Gilead Sciences has promoted James R. Meyers to the role of executive vice president, worldwide commercial operations, with responsibility for commercial operations in North America, Europe, and Japan. Mr. Meyers will become an officer of the company and member of Gilead’s senior leadership team.
Mr. Meyers joined Gilead in 1996 as a regional sales director and has been the senior vice president of North American commercial operations since 2007. In his 20 years at Gilead, Mr. Meyers has been instrumental in building out the company’s commercial operations in North America, including leading product launches in human immunodeficiency virus, oncology, cardiovascular, respiratory, and liver diseases. Prior to Gilead, Mr. Meyers held positions of responsibility in sales, training, marketing, and management with Zeneca Pharmaceuticals and Astra USA.
Source: Gilead Sciences
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription